Pharmacist Check-Ups catch dangerous drug Mix-Ups in cancer care
NCT ID NCT04142567
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether having a clinical pharmacist review medications for cancer patients before they start treatment could prevent drug-related problems. Researchers observed 440 adults with solid tumors who were about to receive chemotherapy, immunotherapy, or oral targeted therapy. The goal was to see how often the pharmacist's advice led to a change in the patient's treatment plan.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEOPLASM are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
APHP -Cochin Hospital and Georges Pompidou European Hospital
Paris, 75014, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a smart digital program restore sleep for cancer survivors?
- AI that reads faces could spot hidden distress in cancer patients
- A smartphone program aims to ease the emotional toll of fertility loss in young cancer survivors
- Island hopping for cancer care: first study maps Survivors' journeys across six caribbean nations
- 4D MRI scans could reveal hidden clues about heart disease and cancer
- Immune cell 'Packages' injected into tumors: a new hope for advanced cancer?